Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Respiratory Research
|
March 14, 2020
Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
Jinping Zheng, Jin-Fu Xu, Martin Jenkins, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 9, 2005
The Living Planet Index: using species population time series to track trends in biodiversity
Jonathan Loh, Rhys E Green, Taylor Ricketts, et al.
Rheumatology (Oxford, England)
|
April 6, 2016
Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis
Iris M Markusse, Robert Landewé, Ron Wolterbeek, et al.
Therapeutic Advances in Respiratory Disease
|
December 24, 2019
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β<sub>2</sub>-agonist fixed-dose combinations in COPD
Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, et al.
Respiratory Research
|
October 8, 2021
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
Omar Usmani, Nicolas Roche, Ezanul Wahab, et al.
Respiratory Medicine
|
May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study
Dave Singh, Klaus F Rabe, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 17, 2020
Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, et al.
Therapeutic Advances in Respiratory Disease
|
August 25, 2021
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler <i>versus</i> dual therapies in patients with COPD: a sub-study of the ETHOS trial
Klaus F Rabe, Fernando J Martinez, Dave Singh, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 6, 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Adaptive Design: Results of 2012 Survey on Perception and Use
Caroline Claire Morgan, Susan Huyck, Martin Jenkins, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Respiratory Research
|
March 14, 2020
Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
Jinping Zheng, Jin-Fu Xu, Martin Jenkins, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 9, 2005
The Living Planet Index: using species population time series to track trends in biodiversity
Jonathan Loh, Rhys E Green, Taylor Ricketts, et al.
Rheumatology (Oxford, England)
|
April 6, 2016
Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis
Iris M Markusse, Robert Landewé, Ron Wolterbeek, et al.
Therapeutic Advances in Respiratory Disease
|
December 24, 2019
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β<sub>2</sub>-agonist fixed-dose combinations in COPD
Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, et al.
Respiratory Research
|
October 8, 2021
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
Omar Usmani, Nicolas Roche, Ezanul Wahab, et al.
Respiratory Medicine
|
May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study
Dave Singh, Klaus F Rabe, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 17, 2020
Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, et al.
Therapeutic Advances in Respiratory Disease
|
August 25, 2021
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler <i>versus</i> dual therapies in patients with COPD: a sub-study of the ETHOS trial
Klaus F Rabe, Fernando J Martinez, Dave Singh, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 6, 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Adaptive Design: Results of 2012 Survey on Perception and Use
Caroline Claire Morgan, Susan Huyck, Martin Jenkins, et al.
Page
of 4